12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

ATLP-03 regulatory update

Atlantic said following its pre-IND meeting with FDA that it plans to develop ATLP-03, an immediate-release, abuse-deterrent formulation...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >